- Release Date: 29/05/25 09:34
- Summary: First patient imaged in Phase III AMPLIFY trial
- Price Sensitive: Yes
- Download Document 328.2KB
- Forums
- ASX - By Stock
- Ann: First patient imaged in Phase III AMPLIFY trial
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
0.90%
!
$2.25

Ann: First patient imaged in Phase III AMPLIFY trial
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.25 |
Change
0.020(0.90%) |
Mkt cap ! $716.6M |
Open | High | Low | Value | Volume |
$2.30 | $2.37 | $2.22 | $1.437M | 625.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 6712 | $2.25 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.26 | 5314 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 8924 | 2.260 |
10 | 23228 | 2.250 |
14 | 44832 | 2.240 |
7 | 34013 | 2.230 |
8 | 15411 | 2.220 |
Price($) | Vol. | No. |
---|---|---|
2.270 | 396 | 2 |
2.280 | 24396 | 9 |
2.290 | 23105 | 10 |
2.300 | 22235 | 9 |
2.310 | 12218 | 7 |
Last trade - 10.15am 17/06/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online